亚辉龙（688575）被证监会立案调查，受损股民可索赔

Core Viewpoint - Shenzhen Yahui Long Biotechnology Co., Ltd. (stock code: 688575) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, as indicated in the notice received on February 6, 2026 [1][4]. Group 1: Investigation Details - The CSRC has issued a formal notice of investigation (No. 00720262) against Yahui Long for alleged violations of the Securities Law and the Administrative Penalty Law of the People's Republic of China [1][4]. - Yahui Long has committed to cooperating with the CSRC during the investigation and will adhere to regulatory disclosure requirements [1][4]. Group 2: Investor Compensation - Affected investors who purchased Yahui Long shares before February 7, 2026, and sold or continued to hold them after February 8, 2026, may be eligible for compensation [2][4]. - The preliminary compensation criteria include investors who bought shares between the company's listing and February 7, 2026, and held or sold them after February 8, 2026 [5]. Group 3: Required Documentation for Claims - Investors must prepare original transaction statements for Yahui Long shares, stamped by the brokerage, showing all trading records from the first purchase to the date of sale or the print date [5][6]. - Additional required documents include copies of the investor's ID, and a confirmation of the securities account information from the brokerage [6].